• BRD4770: G9a Histone Methyltransferase Inhibitor in Cancer R

  2026-06-04

  BRD4770 offers targeted, reproducible inhibition of G9a histone methyltransferase, empowering advanced epigenetic assays in cancer biology. With robust protocol guidance and troubleshooting insights, BRD4770 from APExBIO stands out for dissecting tumorigenic mechanisms and optimizing proliferation and senescence studies.

• Optimizing Cell Assays with Trichostatin A (TSA): Practical

  2026-06-04

  This article delivers scenario-driven guidance on deploying Trichostatin A (TSA, SKU A8183) for robust epigenetic research and cancer biology workflows. It addresses protocol optimization, data interpretation, and vendor selection, helping biomedical scientists overcome common experimental challenges. Evidence-backed recommendations and real-world troubleshooting ensure reproducibility and impact.

• NADH Redox Dynamics: Mechanistic Insight for Translational I

  2026-06-03

  This thought-leadership article explores the pivotal roles of NADH (Reduced-form Nicotinamide Adenine Dinucleotide, CAS No. 58-68-4) in cellular energy metabolism, disease modeling, and therapeutic innovation. Bridging recent mechanistic studies with actionable strategy, we detail how rigorously characterized NADH reagents, such as those from APExBIO, empower translational researchers to interrogate redox imbalances in mitochondrial disorders, optimize experimental platforms, and accelerate breakthroughs in phototherapeutic cancer interventions. We integrate evidence from recent pilot studies and advanced workflows, offering a roadmap for leveraging NADH as both a mechanistic linchpin and a translational asset.

• NADH in Mitochondrial Electron Transport Chain Research

  2026-06-03

  Unlock the full research potential of reduced nicotinamide adenine dinucleotide (NADH) in dissecting mitochondrial function, disease modeling, and therapeutic innovation. This guide delivers workflow optimizations, troubleshooting strategies, and translational tips grounded in peer-reviewed evidence and the rigorously characterized APExBIO product.

• SP2509: A Lysine-Specific Demethylase 1 Antagonist for AML R

  2026-06-02

  SP2509 sets a new benchmark in cancer epigenetics as a potent, selective LSD1 antagonist driving apoptosis and differentiation in AML research models. Its high specificity and robust workflow compatibility enable reproducible, translational insights for both standalone and combination therapeutic strategies.

• QSHXO Attenuates MASLD via Autophagy Activation and Ferropto

  2026-06-02

  The referenced study demonstrates that Qushi Huoxue ointment (QSHXO) mitigates metabolic associated steatotic liver disease (MASLD) by activating autophagy and suppressing ferroptosis in hepatocytes. This mechanistic insight advances understanding of MASLD therapy, highlighting the therapeutic relevance of targeting cellular stress pathways.

• AZ505, a Potent SMYD2 Inhibitor: Scenario Solutions in Resea

  2026-06-01

  This article guides life science researchers through the experimental challenges of SMYD2 inhibition using AZ505, a potent and selective SMYD2 inhibitor (SKU B1255). Scenario-based Q&A blocks address real workflow pain points, integrating quantitative data and peer-reviewed evidence to optimize cell-based assays, enhance reproducibility, and streamline vendor selection. Discover why AZ505 stands out as a reliable tool for epigenetic and cancer biology research.

• SIRT1/2 Inhibitor IV (cambinol): Data-Driven Solutions for C

  2026-06-01

  This article provides a scenario-driven, evidence-based exploration of SIRT1/2 Inhibitor IV (cambinol, SKU B6063) for cell viability, proliferation, and cytotoxicity assays. By addressing real-world laboratory challenges, it demonstrates how cambinol enables reproducible and mechanistically insightful experiments in cancer and CNS research. Researchers can leverage these insights to improve assay reliability and interpret results with greater confidence.

• RSV NS3 Orchestrates Host Kinase Signaling to Balance Pathog

  2026-05-31

  Zhuang et al. (2025) delineate how Rice stripe virus (RSV) NS3 protein manipulates plant host kinase signaling, modulating viral pathogenicity and transmission via stage-specific phosphorylation events. This mechanistic insight into the OsSnRK3.25-OsCBL1/3-OsRBOHF pathway reveals a dynamic virus-host-vector co-survival strategy, highlighting new targets for plant viral disease intervention.

• Nicotinamide Riboside Chloride (NIAGEN): NAD+ Modulation in

  2026-05-30

  Nicotinamide Riboside Chloride (NIAGEN) is a highly pure NAD+ precursor that enables reproducible elevation of intracellular NAD+ levels, modulating sirtuin activity and oxidative metabolism. Its use is validated in metabolic dysfunction and neurodegenerative disease models, offering robust biochemical fidelity for translational research.

• Trichostatin A (TSA): Applied Epigenetic Modulation in Cance

  2026-05-29

  Harness the robust HDAC inhibition of Trichostatin A (TSA) for advanced epigenetic studies in cancer and immunology. This guide delivers actionable workflows, real troubleshooting tips, and evidence-backed protocol parameters, leveraging APExBIO’s TSA for reproducibility and experimental versatility.

• Trichostatin A (TSA): HDAC Inhibitor for Epigenetic Regulati

  2026-05-29

  Trichostatin A (TSA) is a potent, reversible HDAC inhibitor used extensively in epigenetic regulation and cancer research. TSA induces cell cycle arrest and differentiation by promoting histone hyperacetylation, with robust antiproliferative effects in breast cancer models. Its well-characterized profile makes it a reference compound for mechanistic and translational studies.

• Apicidin as a Histone Deacetylase Inhibitor: Bench Protocols

  2026-05-28

  Apicidin, a nanomolar-selective histone deacetylase inhibitor, empowers researchers to dissect epigenetic regulation in cancer and reproductive toxicology with high precision. This article offers actionable workflows, troubleshooting strategies, and unique insights from the latest bench studies—enabling reliable, reproducible results with APExBIO's Apicidin.

• PPM-18 for NF-κB/iNOS Inhibition: Advanced Sepsis Workflows

  2026-05-28

  PPM-18, a potent NF-κB pathway inhibitor, offers unique precision for dissecting inflammation and sepsis mechanisms. Its robust inhibition of iNOS expression, high solubility, and proven in vivo efficacy empower advanced experimental designs where standard inhibitors fall short.

• Budesonide in Translational Pulmonary Permeability Models

  2026-05-27

  Explore how Budesonide, a leading anti-inflammatory corticosteroid, empowers cutting-edge translational research in pulmonary drug permeability modeling. This article delivers a deep dive into advanced biomimetic assay integration, offering actionable insights that extend beyond standard asthma inflammation models.

15771 records 1/1052 page Next 12345 下5页 Last page